Sales Rep Overtime Might Get Supreme Court Review; "Staggering Retroactive Liability" Is Worry
This article was originally published in The Pink Sheet Daily
Executive Summary
The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.
You may also be interested in...
Sales Rep Overtime Issue Remains Unresolved As Supreme Court Declines To Review Novartis, Merck Rulings
Despite a split in circuit courts as to whether sales reps are exempt from overtime pay, the Supreme Court denied certiorari petitions; companies may have to change their overtime compensation systems.
Sales Rep Overtime Issue Remains Unresolved As Supreme Court Declines To Review Novartis, Merck Rulings
Despite a split in circuit courts as to whether sales reps are exempt from overtime pay, the Supreme Court denied certiorari petitions; companies may have to change their overtime compensation systems.
AstraZeneca’s Vimovo Sales Reps Share Detailing Work With Call Center, Website
Fewer AstraZeneca sales representatives may be knocking on physician doors to promote the company’s new arthritis drug Vimovo (naproxen/esomeprazole) compared to previous drug launches.